← Eichor
Study identifier: NCT06597383 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In Acromegaly

Condition: Acromegaly  ·  Sponsor: IRCCS San Raffaele

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is an observational, retrospective, national multicenter study aimed to evaluate the impact and efficacy of Time To Switch (TTS) from first-line to second-line medical therapy in Acromegaly.

This description comes directly from the study's public registry record.

Talk to the study team

Luigi Di Filippo, medical doctor  ·  +39 0226435062  ·  difilippo.luigi@hsr.it

Gabriela Felipe, clinical research nurse  ·  +39 0226435062  ·  felipe.gabriela@hsr.it

Always discuss trial participation with your own doctor first.

Locations (1)

Andrea GiustinaMilan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06597383